VolumeVol. 59 • Number No. 1 • January - March 2021 Back
Fibroblast Growth Factor-23 is associated with High-density lipoprotein in Systemic sclerosis Female patients
Authors: Antonio Álvarez-Cienfuegos, Lucia Cantero-Nieto, José Alberto García-Gómez, José Luis Callejas-Rubio, Javier Martin, Norberto Ortego-Centeno
DOI: 10.65564/pjim.17958d413e
Date of Publication: March 2021
More Details
Authors and Affiliations:
Antonio Álvarez-Cienfuegos, MD, PhD,1 Lucia Cantero-Nieto, MD,2 José Alberto García-Gómez; PhD,3 José Luis Callejas-Rubio, MD, PhD,4 Javier Martin, PhD,5 Norberto Ortego-Centeno, MD, PhD.4,6,7
1 Department of Rheumatology, Hospital Vega-Baja, Alicante, Spain
2 Department of Emergency, Hospital Santa Ana, Granada, Spain
3 Infectious Diseases Unit, Hospital General de Elche, Alicante, Spain
4 Systemic Autoimmune Diseases Unit, Hospital Universitario San Cecilio, Granada, Spain
5 Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain
6 School of Medicine, University of Granada, Granada, Spain
7 Instituto de Investigación Biosanitaria, IBS, Granada, Spain
Corresponding author: Dr Antonio Alvarez de Cienfuegos, MD, PhD,
Department of Rheumatology, Hospital Vega-Baja,
Crta. Orihuela-Almoradi, S/N, 03314 Orihuela (Alicante), Spain
E-mail: [email protected]